INTERSECT ENT
Live / Registered — Registered and renewed (as of 12 Mar 2022)
What this means for you
Registered since 27 Dec 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Dec 2021).
Record
- Serial number
- 77882263
- Registration number
- 4077521
- Mark type
- Stylized text
- Filed
- 30 Nov 2009
- Published for opposition
- 16 Nov 2010
- Registered
- 27 Dec 2011
- Next maintenance due
- 27 Dec 2021
- Attorney of record
- James Leonard
Goods and services
- Class 010 — Medical apparatus: Medical devices consisting of artificial materials for the treatment of ear, nose, throat, sinus and respiratory-related conditions and symptoms, namely, implants comprised of drug-eluting stents; drug delivery systems; surgical devices and instruments for the treatment of ear, nose, throat, sinus and respiratory-related conditions and symptoms
Owner
- INTERSECT ENT, INC., Menlo Park, CA, US
- INTERSECT ENT, INC., PALO ALTO, CA, US
- INTERSECT ENT, INC., PALO ALTO, CA, US
- Sinexus, Inc., Palo Alto, CA, US
Prosecution history
- 16 May 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 May 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 May 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Mar 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Mar 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 12 Mar 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 12 Mar 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Oct 2021 — TEAS SECTION 8 & 9 RECEIVED
- 27 Dec 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 10 Mar 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Mar 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Mar 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Mar 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Mar 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Jan 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED